Rowlandmiller & PARTNERS.ADV reduced its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 6.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,395 shares of the company’s stock after selling 598 shares during the period. Rowlandmiller & PARTNERS.ADV’s holdings in Procter & Gamble were worth $1,575,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of PG. Mainstay Capital Management LLC ADV raised its holdings in Procter & Gamble by 3.0% in the 4th quarter. Mainstay Capital Management LLC ADV now owns 14,945 shares of the company’s stock valued at $2,505,000 after acquiring an additional 435 shares during the last quarter. Birchcreek Wealth Management LLC raised its holdings in Procter & Gamble by 5.0% in the 4th quarter. Birchcreek Wealth Management LLC now owns 11,106 shares of the company’s stock valued at $1,862,000 after acquiring an additional 530 shares during the last quarter. Partners Wealth Management LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $1,004,000. Black Diamond Financial LLC raised its holdings in Procter & Gamble by 74.8% in the 4th quarter. Black Diamond Financial LLC now owns 6,161 shares of the company’s stock valued at $1,033,000 after acquiring an additional 2,637 shares during the last quarter. Finally, BCGM Wealth Management LLC raised its holdings in Procter & Gamble by 29.4% in the 4th quarter. BCGM Wealth Management LLC now owns 2,793 shares of the company’s stock valued at $468,000 after acquiring an additional 634 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have weighed in on the company. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Thursday, January 23rd. DA Davidson reissued a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research note on Thursday, January 23rd. UBS Group reissued a “buy” rating on shares of Procter & Gamble in a research note on Monday, February 10th. Wells Fargo & Company boosted their price objective on shares of Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a research note on Thursday, January 23rd. Finally, Stifel Nicolaus boosted their price objective on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $180.53.
Insider Activity
In other news, insider Marc S. Pritchard sold 90,450 shares of the company’s stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the sale, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
NYSE:PG opened at $170.17 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The firm has a 50-day moving average of $166.04 and a two-hundred day moving average of $169.45. The stock has a market cap of $399.02 billion, a P/E ratio of 27.10, a PEG ratio of 3.76 and a beta of 0.45. The Procter & Gamble Company has a 1-year low of $153.52 and a 1-year high of $180.43.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $21.88 billion during the quarter, compared to analysts’ expectations of $21.66 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 EPS. On average, research analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.01%.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- Why is the Ex-Dividend Date Significant to Investors?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Top Biotech Stocks: Exploring Innovation Opportunities
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.